NCT03283228Unknown不适用
Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 30
- 主要终点
- CD11b and CD56 marker
研究概览
简要总结
- Detect the expression of marker CD56 and CD11b in newly diagnosed cases of adult AML.
- Study correlation between CD56 and CD11b expression with haematological parameters in cases of adult AML.
详细描述
- CD11b expression level is a prognostic biomarker for AML patient. CD11b positivity could predict a poor prognosis for AML patients.
- CD56 antigen expression, an inexpensive, easy to detect and reproduce index, is closely related to the prognosis of AML patients
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Anew diagnosis cases of adult AML
排除标准
- •Pediatric AML .
- •follow up cases of adult AML
结局指标
主要结局
CD11b and CD56 marker
时间窗: 24 month
Detect the expression of marker CD56 and CD11b in newly diagnosed cases of adult AML.
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
AML 12 - Acute myeloid leukaemia Adults (modified)CancerISRCTN17833622Medical Research Council (MRC) (UK)
已完成
不适用
CD155 Expression in Acute Myeloid LeukemiaNeoplasmsHematologic NeoplasmsLeukemia, MyeloidLeukemia, Myeloid, AcuteLeukemiaNCT06369662Assiut University93
已完成
3 期
Adults with Acute Myeloid Leukaemia or High-Risk Myelodysplastic Syndrome (AML19)Acute myeloid leukaemia and myelodysplastic syndromeCancerISRCTN78449203Cardiff University (UK)1,033
已完成
不适用
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid LeukemiaChildhood Acute Monoblastic Leukemia (M5a)Childhood Acute Monocytic Leukemia (M5b)Childhood Acute Myeloblastic Leukemia Without Maturation (M1)Childhood Acute Myeloid Leukemia/Other Myeloid MalignanciesChildhood Acute Myelomonocytic Leukemia (M4)NCT01642121Children's Oncology Group20
Unknown
2 期
11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia SyndromesParkinson DiseaseNCT03555292Oriental Neurosurgery Evidence-Based-Study Team200